On September 11, 2025, at the BIOHK2025 International Biotechnology Convention held in Hong Kong, Deep Harbour Cell Valley achieved another milestone. Professor Wang Jianxun, Chief Scientist of the company, was invited to deliver a keynote speech at the main forum titled "Manufacture of CAR-T/CAR-NK cells using eVLP-based Cas9/gRNA RNP delivery system". He comprehensively shared the latest scientific research achievements and industrialization progress of Deep Harbour Cell Valley in the fields of gene editing delivery systems and key technologies for cell therapy, receiving high praise from attending experts.

During the conference, on behalf of Deep Harbour Cell Valley, Professor Wang Jianxun proudly received the "Global Life Science Industrial Park Leader Award" presented by the convention. This prestigious honor not only fully acknowledges the outstanding contributions of Deep Harbour Cell Valley in the field of cell and gene therapy (CGT) technology R&D and industrialization, but also signifies that its comprehensive strength and innovation capability have gained extensive recognition from the international industry.

Leveraging the high-end international platform of BIOHK2025, Deep Harbour Cell Valley actively engaged in global dialogues at the forefront of life sciences, showcasing to the world the innovation vitality, scientific research strength, and industrialization achievements of Chinese CGT enterprises. In the future, the company will continue to rely on Hong Kong's role as an international window, accelerate its global strategic layout, deepen cooperation with top international institutions, and jointly promote innovation and translation in cell and gene therapy technologies, bringing more new treatment options and hope for life to patients worldwide.